Assignment: Treatment of Substance-Related and Addictive Dis

Assignment: Treatment of Substance-Related and Addictive Disorders Hallucinogen -Related Disorders Explain the diagnostic criteria for your assigned      substance-related and addictive disorder ( Hallucinogen related      disorder). Explain the evidenced-based psychotherapy and      psychopharmacologic treatment for your assigned substance-related and      addictive disorder. Describe clinical features that you would expect to      observe in a client that may have the substance-related and addictive      disorder you were assigned. Align the clinical features with the DSM-5      criteria. Support your rationale with references to the Learning      Resources or other academic resources.  Required Readings( Need 3 + reference). American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer. · Chapter 20, “Substance Use and Addictive Disorders” (pp. 616–693) Stahl, S. M. (2017). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (6th ed.). New York, NY: Cambridge University Press. To access information on specific medications, click on The Prescriber’s Guide, 6th Ed. tab on the Stahl Online website and select the appropriate medication.     Alcohol abstinence Alcohol dependence Alcohol withdrawal Nicotine addiction Opioid dependence Reversal of    benzodiazepine effects   acamprosate   disulfiram nalmefene   naltrexone chlordiazepoxide   clonidine   clorazepate   diazepam   lorazepam   oxazepam bupropin   varenicline buprenorphine   naltrexone flumazenil Note: For more information about buprenorphine, see https: //www.samhsa.gov/medication-assisted-treatment/qualify-nps-pas-waivers Required Media Ashwood, D. (Producer). (n.d.-a). Mindfulness-based relapse prevention for addictions: Volume I [Video file]. Mill Valley, CA: Psychotherapy.net. Note: The approximate length of this media piece is 69 minutes.  Ashwood, D. (Producer). (n.d.-b). Mindfulness-based relapse prevention for addictions: Volume II [Video file]. Mill Valley, CA: Psycotherapy.net. Note: The approximate length of this media piece is 126 minutes.  Optional Resources Bechtold, J., Simpson, T., White, H. R., & Pardini, D. (2015). Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychology of Addictive Behaviors, 29(3), 552–563. doi:10.1037/adb0000103 Note: You will access this article from the Walden Library databases. Borchardt, D. (2017). National Academy of Sciences pushes for rescheduling of marijuana. Forbes. Retrieved from https://www.forbes.com/sites/debraborchardt/2017/01/18/national-academy-of-sciences-suggests-removing-barriers-to-cannabis-research-basically-deschedule/#22269c753f76 Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications. · Chapter 46, “Alcohol-Related Disorders” · Chapter 47, “Sedative-, Hypnotic-, or Anxiolytic-Related Disorders” · Chapter 48, “Opioid-Related Disorders: Opioid Detoxification” · Chapter 49, “Opioid-Related Disorders: Antagonist Treatment” · Chapter 50, “Opioid-Related Disorders: Agonist Maintenance Treatment” · Chapter 51, “Hallucinogen-Related Disorders · Chapter 52, “Cannabis-Related Disorders” · Chapter 53, “Club Drug Addiction” · Chapter 54, “Stimulant-Related Disorders” · Chapter 55, “Nicotine-Related Disorders” · Chapter 56, “Individual Therapy for Substance Use Disorders” · Chapter 57, “Cognitive, Behavioral, and Motivational Therapies for Substance Use Disorders” · Chapter 58, “Group Therapy for Substance Use Disorders” · Chapter 59, “Family Therapy in Substance Abuse Treatment” · Chapter 60, “Network Therapy for Substance Use Disorders” · Chapter 61, “Pain and Addiction” · Chapter 62, “Gambling Disorder” Substance Abuse and Mental Health Services Administration (SAMHSA). (2013b). TIP 42: Substance abuse treatment for persons with co-occurring disorders. Retrieved from http://store.samhsa.gov/product/TIP-42-Substance-Abuse-Treatment-for-Persons-With-Co-Occurring-Disorders/SMA13-3992  Note: This document is available as free download. Substance Abuse and Mental Health Services Administration (SAMHSA). (2013b). TIP 48: Managing depressive symptoms in substance abuse clients during early recovery. Retrieved from http://store.samhsa.gov/product/TIP-48-Managing-Depressive-Symptoms-in-Substance-Abuse-Clients-During-Early-Recovery/SMA13-4353  Note: This document is available as free download.